Subchorionic hematomas and the presence of autoantibodies
Laxmi V. Baxi, MD, and Melissa M. Pearlstone, MD
New York, New York
Five cases of subchorionic hematoma detected by ultrasonography in patients with threatened abortion are
presented. Three of these subjects had antinuclear antibodies, and the remaining two subjects had
anticardiolipin antibodies. We recommend that patients with subchorionic hematomas be tested for autoantibodies regardless of their obstetric history. (AM J OBSTET GVNECOL 1991 ;165:1423-4.)
Key words: Subchorionic hematoma, autoantibodies, anticardiolipin antibodies, antinuclear antibodies, habitual abortion
Lupus and allied disorders, as well as anticardiolipin antibodies, are associated with poor fetal outcome. Recently, a high prevalence of antinuclear antibody-positive serum was demonstrated in patients with recurrent pregnancy losses.' The incidence of anticardiolipin antibody in the general obstetric population is I % to 2%; it is approximately 40% in patients with a poor obstetric history.
From the Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, and Sloane Hospital for Women at Columbia Presbyterian Medical.Center. Received for publication April 10, 1991; accepted April 24, 1991. Reprint requests: Laxmi V. Baxi, MD, Department of Obstetrics and Gynecology, Columbia Presbyterian M edical Center, 622 West 168th Street, New York, NY 10032. 611 130675
In this manuscript we describe five cases of subchorionic hematomas that were associated with autoantibodies. The patients presented with vaginal bleeding in the late first trimester or early second trimester of pregnancy. The clinical details are summarized in Table 1.
Three of these patients had had one or more spontaneous abortions. One of the remaining two patients was primigravid; the other had had an induced abortion . In all these patients subchorionic hematomas were detected by ultrasonography that was performed because of threatened abortion. Anticardiolipin or antinuclear antibodies were also detected.
The presence of vaginal bleeding during early pregnancy is associated with a 10% to 15% risk of spontaneous abortion. The incidence of a subchorionic he-
Table I. Clinical features of patients with subchorionic hematomas
Patient and obstetric history Current pregnancy Treatment Pregnancy outcome
32 yr old, gravida 2, Bleeding associated with sub- ANA Cerclage at 13 wk, prednisone Normal spontaneous vaginal de-para 1, previous chorionic hematoma noted 1: 1280 30 mg orally on alternate livery at term, male infant spontaneous at 17 wk days at 10 wk abortion at 20 wk associated with premature cervi-cal dilatation
28 yr old, gravida 4, Bleeding and subchorionic ANA Aspirin 75 mg daily begun at Cesarean section for breech at para 0-0-3-0, hematoma noted at 15 wk 1:160 II wk term, female infant spontaneous abortions at 24 wk and 12 wk
35 yr old, gravida 6, Bleeding at 13 wk, subcho- ANA Aspirin 75 mg daily begun at Normal spontaneous vaginal de-para 1-0-5-1, vol- rionic hematoma noted at 1 :40 9 wk, prednisone 30 mg livery at term, female infant untary termina- lS wk daily begun at 15 wk tion of pregnancy spontaneous abortions at 12 and 6 wk
24 yr old, gravida I , Spotting at 6 wk, subcho- ACL Expectant Patient at 14 wk of pt'egnancy para I , one vol- rionic hematoma noted at Ab(+) untary term ina- 6 wk 5 days and disap-tion of pregnancy pea red at 13 wk
32 yr old, gravida 1, Bleeding at 11 wk, subcho- ACL Aspirin 75 mg daily begun at Neonatal death at 24.8 wk para 0 rionic hematoma persisted Ab(+) 13 wk
ANA, Antinuclear antibody; ACL, anticardiolipin antibody.
1423
1424 Baxi and Pearlstone November 1991 Am J Obstet Gynecol
Fig. 1. Arrow points to subchorionic hematoma.
matoma detected by ultrasonography in women with threatened abortions varies widely (11 % to 62%).2.3 Several studies have demonstrated that patients who have a subchorionic hematoma are more likely to abort (13% to 40%).2.5 Pedersen et aI.' suggested that the high rate
of spontaneous abortions (40%) observed in subjects with subchorionic hematomas may have been due to a patient selection bias (most of those patients had a poor obstetric history). This theory is supported in a study by Mandruzzato et al.,' who found that 50% of women who presented with an intrauterine hematoma had had a previous spontaneous abortion. In any case, tlie etiologic and epidemiologic factors of subchorionic hematomata remain unclear.
We propose that the presence of autoantibodies may be an etiologic factor. These antibodies may increase the tendency of platelets to aggregate, which leads to thrombosis and /or vasculitis and thereby to an increased likelihood of a subchorionic hematoma. Al
though subplacental bleeding in patients with lupus has been reported,6 subchorionic hematomas have not been described.
We recommend that patients with threatened abortion and subchorionic hematomas detected by ultrasonography (Fig. I) be evaluated for autoantibodies, regardless of obstetric history. Those patients with a poor obstetric history and persistent hematomas should be treated aggressively with low-dose aspirin and/or corticosteroid medications.
REFERENCES
1. Xu L, Chang V, Murphy A, et at. kntinuclear antibodies in sera of patients with recurrent pregnancy wastage. AM J OBSTET GYNECOL 1990;163:1493.
2. J oupilla P. Clinical consequences after ultrasonic diagnosis of intrauterine hematoma in threatened abortion. JCU 1985; 13: 107.
3. Ylostalo P, Ammala P, Seppala M. Intrauterine hematoma and placental proteins in patients with uterine bleeding during pregnancy. Br J Obstet Gynaecol 1984;91:353.
4. Pedersen JF, Mantoni M. Large intrauterine hematomata in threatened miscarriage. Br J Obstet Gynaecol 1990; 97:75 .
5. Mandruzzato GP, Dottavio G, Rustico MA, Fontana A, Bogatti P. The intrauterine hematoma: diagnostic and clinical aspects.JCU 1989;17:503.
6. Hanly JG, Gladman DD, Rose TH, Laskin CA, Urowitz MB. Lupus in pregnancy. Arthritis Rheum 1988;31:358.